Potential new autism drug shows promise in miceNovember 14, 2017
LA JOLLA, Calif. -- Nov. 14, 2017 -- Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, called NitroSynapsin, largely corrected electrical, behavioral and brain abnormalities in the mice.
NitroSynapsin is intended to restore an electrical signaling imbalance in the brain found in virtually all forms of autism spectrum disorder (ASD).
"This drug candidate is poised to go into clinical trials, and we think it might be effective against multiple forms of autism," said senior investigator Stuart Lipton, M.D., Ph.D., Professor and Hannah and Eugene Step Chair at The Scripps Research Institute (TSRI), who is also a clinical neurologist caring for patients.
The research, published on today in the journal Nature Communications, was a collaboration involving scientists at the Scintillon Institute; the University of California, San Diego School of Medicine; Sanford Burnham Prebys Medical Discovery Institute and other institutions. Lipton's fellow senior investigators on the project were Drs. Nobuki Nakanishi and Shichun Tu of the Scintillon Institute in San Diego.
ASD is brain development disorder that affects 1 in 68 children in the United States alone. Because ASD has been diagnosed more often in recent years, most Americans now living with autism diagnoses are children--roughly 2.4 percent of boys and 0.5 percent of girls.
Genetic Analysis Leads to Potential Treatment
The new study stemmed from a 1993 study in which Lipton and his laboratory, then at Harvard Medical School, identified a gene called MEF2C as a potentially important factor in brain development.
This breakthrough led Lipton and colleagues to the discovery that disrupting the mouse version of MEF2C in the brain, early in fetal development, causes mice to be born with severe, autism-like abnormalities. Since that discovery in mice in 2008, other researchers have reported many cases of children who have a very similar disorder, resulting from a mutation to one copy of MEF2C (human DNA normally contains two copies of every gene, one copy inherited from the father and one from the mother). The condition is now called MEF2C Haploinsufficiency Syndrome (MHS).
"This syndrome was discovered in people only because it was first discovered in mice--it's a good example of why basic science is so important," Lipton said.
MEF2C encodes a protein that works as a transcription factor, like a switch that turns on the expression of many genes. Although MHS accounts for only a small proportion of autism disorder cases, large-scale genomic studies in recent years have found that mutations underlying various autism disorders frequently involve genes whose activity is switched on by MEF2C.
"Because MEF2C is important in driving so many autism-linked genes, we're hopeful that a treatment that works for this MEF2C-haploinsufficiency syndrome will also be effective against other forms of autism," Lipton said, "and in fact we already have preliminary evidence for this."
For the study, the researchers created a laboratory model of MHS by engineering mice to have--like human children with MHS--just one functioning copy of the mouse version of MEF2C, rather than the usual two copies. The mice showed impairments in spatial memory, abnormal anxiety and abnormal repetitive movements, plus other signs consistent with human MHS. Analyses of mouse brains revealed a host of problems, including an excess in key brain regions of excitatory signaling (which causes neurons to fire) over inhibitory signaling (which suppresses neuronal activity).
In short, these two important kinds of brain signals were out of balance. A similar excitatory/inhibitory (E/I) imbalance is seen in most forms of ASD and is thought to explain many of the core features of these disorders, including cognitive and behavioral problems and an increased chance of epileptic seizures.
The researchers treated the MHS-mice for three months with NitroSynapsin, an aminoadamantane nitrate compound related to the Alzheimer's FDA-approved drug memantine, which was previously developed by Lipton's group. NitroSynapsin is known to help reduce excess excitatory signaling in the brain, and the team found that the compound did reduce the E/I imbalance and also reduced abnormal behaviors in the mice and boosted their performance on cognitive/behavioral tests--in some cases restoring performance essentially to normal.
Lipton and colleagues are currently testing the drug in mouse models of other autism disorders, and they hope to move NitroSynapsin into clinical trials with a biotechnology partner.
The work also has support from parents of children with MHS. "We are all hanging on to the hope that one day our children will be able to speak, to understand and to live more independent lives," said Michelle Dunlavy, who has a son with MHS.
In fact, Lipton's group is also now using stem cell technology to create cell-based models of MHS with skin cells from children who have the syndrome--and NitroSynapsin appears to work in this 'human context' as well. Dunlavy and other parents of children with MHS recently organized an international, Facebook-based support group, which is coordinating to assist in Lipton's research going forward.
In an amazing twist, the scientific team also found in Alzheimer's disease models that the new NitroSynapsin compound improves synapse function, the specialized areas for communication between nerve cells. Thus, the ability of the drug to improve 'network' communication in the brain may eventually lead to its use in several neurological diseases.
About The Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists -- including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine -- work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see http://www.scripps.edu.
Scripps Research Institute
Related Autism Articles:
Exposure to ozone in the environment puts individuals with high levels of genetic variation at an even higher risk for developing autism than would be expected just by adding the two risk factors together, a new analysis shows.
An algorithm based on levels of metabolites found in a blood sample can accurately predict whether a child is on the autism spectrum of disorder (ASD), based upon a recent study.
Autism spectrum disorders (ASD) affect around one percent of the world's population and are characterized by a range of difficulties in social interaction and communication.
A new study from Autism Speaks' MSSNG program expands understanding of autism's complex causes and may hold clues for the future development of targeted treatments.
A new report in Biological Psychiatry reports that brain alterations in infants at risk for autism may be widespread and affect multiple systems, in contrast to the widely held assumption of impairment specifically in social brain networks.
Humans are resilient, even facing the toughest of life's challenges.
Recognizing a need to better understand the biology that produces Autism Spectrum Disorder (ASD) symptoms, scientists at Duke-NUS Medical School (Duke-NUS) and the National Neuroscience Institute (NNI), Singapore, have teamed up and identified a novel mechanism that potentially links abnormal brain development to the cause of ASDs.
Using a visual test that is known to prompt different reactions in autistic and normal brains, Harvard researchers have shown that those differences were associated with a breakdown in the signaling pathway used by GABA, one of the brain's chief inhibitory neurotransmitters.
The release of oxytocin leads to an increase in the production of anandamide, which causes mice to display a preference for interacting socially.
The Autism Science Foundation, a not-for-profit organization dedicated to supporting and funding autism research, today announced the launch of the Autism Sisters Project, a new initiative that will give unaffected sisters of individuals with autism the opportunity to take an active role in accelerating research into the 'Female Protective Effect.'
Related Autism Reading:
Uniquely Human: A Different Way of Seeing Autism
by Barry M. Prizant (Author)
Winner of the Autism Society of America’s Dr. Temple Grandin Award for the Outstanding Literary Work in Autism
A groundbreaking book on autism, by one of the world’s leading experts, who portrays autism as a unique way of being human—this is “required reading....Breathtakingly simple and profoundly positive” (Chicago Tribune).
Autism therapy typically focuses on ridding individuals of “autistic” symptoms such as difficulties interacting socially, problems in communicating, sensory challenges, and repetitive behavior patterns. Now Dr. Barry M. Prizant... View Details
Autism Breakthrough: The Groundbreaking Method That Has Helped Families All Over the World
by Raun K. Kaufman (Author)
As a boy, Raun Kaufman was diagnosed by multiple experts as severely autistic, with an IQ below 30, and destined to spend his life in an institution. Years later, Raun graduated with a degree in Biomedical Ethics from Brown University and has become a passionate and articulate autism expert and educator with no trace of his former condition.
So what happened?
Thanks to The Son-Rise Program, a revolutionary method created by his parents, Raun experienced a full recovery from autism. (His story was recounted in the best-selling book Son-Rise: The Miracle Continues and in the... View Details
The Reason I Jump: The Inner Voice of a Thirteen-Year-Old Boy with Autism
by Naoki Higashida (Author), KA Yoshida (Translator), David Mitchell (Translator)
“One of the most remarkable books I’ve ever read. It’s truly moving, eye-opening, incredibly vivid.”—Jon Stewart, The Daily Show
NAMED ONE OF THE BEST BOOKS OF THE YEAR BY
NPR • The Wall Street Journal • Bloomberg Business • Bookish
FINALIST FOR THE BOOKS FOR A BETTER LIFE FIRST BOOK AWARD • NEW YORK TIMES BESTSELLER
You’ve never read a book like The Reason I Jump. Written by Naoki Higashida, a very smart, very self-aware, and very charming thirteen-year-old boy with autism, it is a... View Details
A Parent's Guide to High-Functioning Autism Spectrum Disorder, Second Edition: How to Meet the Challenges and Help Your Child Thrive
by Sally Ozonoff (Author), Geraldine Dawson (Author), James C. McPartland (Author)
Many tens of thousands of parents have found the facts they need about high-functioning autism spectrum disorder (ASD), including Asperger syndrome, in this indispensable guide. Leading experts show how you can work with your child's unique impairments--and harness his or her capabilities. Vivid stories and real-world examples illustrate ways to help kids with ASD relate more comfortably to peers, learn the rules of appropriate behavior, and succeed in school. You'll learn how ASD is diagnosed and what treatments and educational supports really work. Updated with the latest research and... View Details
An Early Start for Your Child with Autism: Using Everyday Activities to Help Kids Connect, Communicate, and Learn
by Sally J. Rogers (Author), Geraldine Dawson (Author), Laurie A. Vismara (Author)
Cutting-edge research reveals that parents can play a huge role in helping toddlers and preschoolers with autism spectrum disorder (ASD) connect with others and live up to their potential. This encouraging guide from the developers of a groundbreaking early intervention program provides doable, practical strategies you can use every day. Nearly all young kids—including those with ASD—have an amazing capacity to learn. Drs. Sally Rogers, Geraldine Dawson, and Laurie Vismara make it surprisingly simple to turn daily routines like breakfast or bath time into fun and rewarding learning... View Details
Autism Spectrum Disorder (revised): The Complete Guide to Understanding Autism
by Chantal Sicile-Kira (Author)
Newly revised and updated, this award-winning guide covers every aspect of understanding and living with autism today
Comprehensive and authoritative, Autism Spectrum Disorders explains all aspects of the condition, and is written for parents, educators, caregivers, and others looking for accurate information and expert insight. Newly updated to reflect the latest research, treatment methods, and DSM-V criteria, this invaluable book covers:
• The causes of autism spectrum disorders
• Getting an accurate diagnosis
• Treatments based on behavioral,... View Details
I See Things Differently: A First Look at Autism (A First Look At...Series)
by Pat Thomas (Author)
Psychotherapist and counselor Pat Thomas puts her gentle, yet straightforward approach to work in this new addition to Barron’s highly acclaimed A First Look At...Series. This book will help children understand what autism is and how it affects someone who has it. A wonderful catalyst for discussion that will help children to better understand and support autistic classmates or siblings. The story line is simple and easily accessible to younger children, who will learn that exploring the personal feelings around social issues is a first step in dealing with them. Full-color... View Details
Eating for Autism: The 10-Step Nutrition Plan to Help Treat Your Child’s Autism, Asperger’s, or ADHD
by Elizabeth Strickland (Author)
What your child eats has a major impact on his brain and body function. Eating for Autism is the first book to explain how an autism, Asperger's, PDD-NOS, or ADHD condition can effectively be treated through diet.
Eating for Autism presents a realistic 10-step plan to change your child's diet, starting with essential foods and supplements and moving to more advanced therapies like the Gluten-Free Casein-Free diet. Parents who have followed Strickland's revolutionary plan have reported great improvements in their child's condition, from his mood, sleeping patterns, learning... View Details
The Un-Prescription for Autism: A Natural Approach for a Calmer, Happier, and More Focused Child
by Janet Lintala (Author), Elizabeth Mumper MD FAAP (Foreword), Martha W. Murphy (Foreword)
Each year, more than 50,000 U.S. families receive an autism diagnosis. On top of turmoil and worry, they share the same urgent question: What can we do to help our child?
The answers parents find can be contradictory...even dangerous. The conventional approach (employed by too many pediatricians) is to medicate difficult behaviors into submission--suppressing symptoms while leaving underlying health challenges untouched. Surfing the Internet for alternatives just leads to confusion.
Now, Dr. Janet Lintala, founder of the Autism Health center and an autism mom herself,... View Details
We're Amazing 1,2,3! A Story About Friendship and Autism (Sesame Street) (Big Golden Book)
by Leslie Kimmelman (Author), Mary Beth Nelson (Illustrator)
A Sesame Street Big Golden Book about a new character with autism.
We're Amazing 1,2,3! is the first Sesame Street storybook to focus on autism, which, according to the most recent US government survey, may, in some form, affect as many as one in forty-five children. It's part of Sesame Street's autism initiative that has expanded to include a new character with autism. Elmo introduces his longtime friend Julia to Abby, who's a little confused at first because Julia isn't saying hello. Elmo explains that Julia has autism, so she does things a little differently. Julia... View Details